These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 118557)

  • 1. Pretransfusion blood group serology. Limited value of the antiglobulin phase of the crossmatch when a careful screening test for unexpected antibodies is performed.
    Heistø H
    Transfusion; 1979; 19(6):761-3. PubMed ID: 118557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the crossmatch in testing for serologic incompatibility.
    Oberman HA; Barnes BA; Steiner EA
    Transfusion; 1982; 22(1):12-6. PubMed ID: 6801826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a manual hexadimethrine bromide-antiglobulin test with saline- and albumin-antiglobulin tests for pretransfusion testing.
    Mintz PD; Anderson G
    Transfusion; 1987; 27(2):134-7. PubMed ID: 3824470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the polyethyleneglycol antiglobulin test in the detection and identification of erythrocyte antibodies].
    Jiménez Marco MT; Hernández Maraver D; Rodríguez de la Rua A; de la Cámara Mendizábal C; Canales Albendea M; Jiménez Yuste V; Hernández Navarro F
    Sangre (Barc); 1998 Feb; 43(1):21-4. PubMed ID: 9577178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three low-ionic-strength solutions for routine pretransfusion testing: antibody screening/identification, cross-matching, immune anti-ABO detection, and direct antiglobulin tests.
    Kaspi E; Mallié F; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
    Transfusion; 2009 Dec; 49(12):2772-3. PubMed ID: 20163691
    [No Abstract]   [Full Text] [Related]  

  • 7. [The importance of immunohematology testing in the neonatal period].
    Bujandrić N; Milanović MK
    Med Pregl; 2013; 66(7-8):317-21. PubMed ID: 24069814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incompatible crossmatch following nonreactive antibody detection test. Frequency and cause.
    Mintz PD; Haines AL; Sullivan MF
    Transfusion; 1982; 22(2):107-10. PubMed ID: 7071913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the immediate spin crossmatch when used for detecting ABO incompatibility.
    Berry-Dortch S; Woodside CH; Boral LI
    Transfusion; 1985; 25(2):176-8. PubMed ID: 3984013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-stage papain-indirect antiglobulin test and LISS direct agglutination are not appropriate for pretransfusion screening for unexpected antibodies.
    Pereira A; Mazzara R; Gelabert A; Castillo R
    Haematologica; 1991; 76(6):475-8. PubMed ID: 1820984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.
    Pinkerton PH; Coovadia AS; Goldstein J
    Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted?
    Judd WJ; Fullen DR; Steiner EA; Davenport RD; Knafl PC
    Transfusion; 1999 Mar; 39(3):295-9. PubMed ID: 10204593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of RhD typing and the antiglobulin test in pretransfusion compatibility tests for Taiwanese.
    Lin M; Broadberry RE
    Vox Sang; 1994; 67 Suppl 5():28-9. PubMed ID: 7701822
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk of abbreviating the major crossmatch in urgent or massive transfusion.
    Oberman HA; Barnes BA; Friedman BA
    Transfusion; 1978; 18(2):137-41. PubMed ID: 417431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.
    Judd WJ; Barnes BA; Steiner EA; Oberman HA; Averill DB; Butch SH
    Transfusion; 1986; 26(3):220-4. PubMed ID: 3705135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
    Thomas L; Tuscany FL; Wilner GD
    Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with the routine use of an abbreviated crossmatch.
    Shulman IA; Nelson JM; Saxena S; Thompson JC; Okamoto M; Kent DR; Nakayama RK
    Am J Clin Pathol; 1984 Aug; 82(2):178-81. PubMed ID: 6465079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proposal for compatibility testing incorporating the manual hexadimethrine bromide (Polybrene) test.
    Steane EA; Steane SM; Montgomery SR; Pearson JR
    Transfusion; 1985; 25(6):540-4. PubMed ID: 4071598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Irregular agglutinins and the compatibility test: the elements of choice].
    Rouger P; Salmon C
    Rev Fr Transfus Immunohematol; 1983 Feb; 26(1):5-13. PubMed ID: 6407087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.